Replimune Group Inc (REPL)

Name: Replimune Group Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$0.0

Net Income

-$70.9M

Operating Margin

N/A

Free Cash Flow

-$199M

Debt / Assets

24.6%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Replimune Group Inc (REPL).
Income Statement (Quarterly)	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	0	0	0	0
Cost of Revenue	0	0	0	-736,000
Gross Profit	0	0	0	736,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	18,728,000	26,414,000	0	24,302,000
Operating Expenses	71,868,000	84,291,000	90,422,000	79,325,000
Operating Income	-71,868,000	-84,291,000	-90,422,000	-79,325,000
Interest Expense	1,980,000	518,000	1,996,000	-8,025,000
Income Before Tax	-71,241,000	-83,100,000	-86,693,000	-74,237,000
Income Tax Expense	-311,000	0	0	739,000
Net Income	-70,930,000	-83,100,000	-86,693,000	-74,130,000
Per Share
EPS	-0.77	-0.90	-0.95	-0.82
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Replimune Group Inc (REPL).
Income Statement (Annual)	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31
Revenue	0	0	0	0	0
Cost of Revenue	0	2,655,000	2,447,000	4,575,000	0
Gross Profit	0	-2,655,000	-2,447,000	-4,575,000	0
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	0	59,810,000	50,553,000	38,769,000	23,201,000
Operating Expenses	261,627,000	234,773,000	174,166,000	115,144,000	79,955,000
Operating Income	-261,627,000	-234,773,000	-177,080,000	-118,314,000	-79,955,000
Interest Expense	7,893,000	6,660,000	4,160,000	2,223,000	3,060,000
Income Before Tax	-246,829,000	-215,386,000	-173,996,000	-118,036,000	-80,870,000
Income Tax Expense	468,000	408,000	288,000	1,164,000	0
Net Income	-247,297,000	-215,794,000	-174,284,000	-118,036,000	-80,870,000
Per Share
EPS	-3.07	-3.24	-2.99	-2.26	-1.75
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Replimune Group Inc (REPL).
Balance Sheet (Quarterly)	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Assets
Cash and Cash Equivalents	111,119,000	74,457,000	146,590,000	105,948,000
Short Term Investments	372,685,000	346,211,000	436,796,000	289,707,000
Net Receivables	3,725,000	4,922,000	2,939,000	3,055,000
Inventory	0	0	0	0
Total Current Assets	495,880,000	433,667,000	592,603,000	403,977,000
Property Plant Equipment	52,545,000	52,355,000	52,352,000	55,579,000
Goodwill and Intangibles	0	0	0	0
Total Assets	551,328,000	487,722,000	646,591,000	461,192,000
Liabilities
Account Payables	12,463,000	2,578,000	5,364,000	3,732,000
Short Term Debt	3,983,000	3,879,000	3,757,000	3,632,000
Total Current Liabilities	62,362,000	40,438,000	33,825,000	20,756,000
Long Term Debt	72,182,000	71,990,000	57,002,000	29,207,000
Total Liabilities	135,485,000	113,214,000	91,299,000	49,963,000
Shareholders Equity
Retained Earnings	-948,579,000	-701,282,000	-485,488,000	-311,204,000
Total Shareholders Equity	415,843,000	374,508,000	555,292,000	411,229,000

Balance sheet annual history for Replimune Group Inc (REPL).
Balance Sheet (Annual)	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31
Assets
Cash and Cash Equivalents	111,119,000	74,457,000	146,590,000	105,948,000	182,518,000
Short Term Investments	372,685,000	346,211,000	436,796,000	289,707,000	293,784,000
Net Receivables	3,725,000	4,922,000	2,939,000	3,055,000	2,953,000
Inventory	0	0	0	0	0
Total Current Assets	495,880,000	433,667,000	592,603,000	403,977,000	483,747,000
Property Plant Equipment	52,545,000	52,355,000	52,352,000	55,579,000	57,715,000
Goodwill and Intangibles	0	0	0	0	0
Total Assets	551,328,000	487,722,000	646,591,000	461,192,000	543,098,000
Liabilities
Account Payables	12,463,000	2,578,000	5,364,000	3,732,000	2,355,000
Short Term Debt	3,983,000	3,879,000	3,757,000	3,632,000	3,457,000
Total Current Liabilities	62,362,000	40,438,000	33,825,000	20,756,000	14,547,000
Long Term Debt	72,182,000	71,990,000	57,002,000	29,207,000	29,823,000
Total Liabilities	135,485,000	113,214,000	91,299,000	49,963,000	44,370,000
Shareholders Equity
Retained Earnings	-948,579,000	-701,282,000	-485,488,000	-311,204,000	-193,168,000
Total Shareholders Equity	415,843,000	374,508,000	555,292,000	411,229,000	498,728,000

Cash flow quarterly history for Replimune Group Inc (REPL).
Cash Flow Statement (Quarterly)	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Operating Activities
Net Income	-247,297,000	-215,794,000	-174,284,000	-118,036,000
Depreciation & Amortization	3,502,000	2,655,000	2,447,000	2,147,000
Stock Based Compensation	35,044,000	34,125,000	28,131,000	24,254,000
Change in Working Capital	24,081,000	5,483,000	15,124,000	7,235,000
Operating Cash Flow	-192,250,000	-185,467,000	-128,050,000	-82,180,000
Investing Activities
Capital Expenditure	-6,687,000	-5,662,000	-2,270,000	-2,336,000
Investments	-6,687,000	-5,662,000	-2,270,000	-2,336,000
Investing Cash Flow	-23,796,000	97,201,000	-142,502,000	-1,806,000
Financing Activities
Debt Repayment	-599,000	14,524,000	-365,000	-264,000
Common Stock Issued/Repurchased	155,728,000	1,759,000	187,292,000	6,862,000
Dividends Paid	0	0	0	0
Financing Cash Flow	252,396,000	16,283,000	311,303,000	6,598,000
Summary
Free Cash Flow	-198,937,000	-191,129,000	-130,320,000	-84,516,000
Net Change in Cash	36,665,000	-72,069,000	40,642,000	-76,570,000

Cash flow annual history for Replimune Group Inc (REPL).
Cash Flow Statement (Annual)	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31
Operating Activities
Net Income	-247,297,000	-215,794,000	-174,284,000	-118,036,000	-80,870,000
Depreciation & Amortization	3,502,000	2,655,000	2,447,000	2,147,000	1,711,000
Stock Based Compensation	35,044,000	34,125,000	28,131,000	24,254,000	11,790,000
Change in Working Capital	24,081,000	5,483,000	15,124,000	7,235,000	3,510,000
Operating Cash Flow	-192,250,000	-185,467,000	-128,050,000	-82,180,000	-61,389,000
Investing Activities
Capital Expenditure	-6,687,000	-5,662,000	-2,270,000	-2,336,000	-2,392,000
Investments	-6,687,000	-5,662,000	-2,270,000	-2,336,000	-2,392,000
Investing Cash Flow	-23,796,000	97,201,000	-142,502,000	-1,806,000	-188,776,000
Financing Activities
Debt Repayment	-599,000	14,524,000	-365,000	-264,000	-10,145,000
Common Stock Issued/Repurchased	155,728,000	1,759,000	187,292,000	6,862,000	286,107,000
Dividends Paid	0	0	0	0	0
Financing Cash Flow	252,396,000	16,283,000	311,303,000	6,598,000	372,462,000
Summary
Free Cash Flow	-198,937,000	-191,129,000	-130,320,000	-84,516,000	-63,781,000
Net Change in Cash	36,665,000	-72,069,000	40,642,000	-76,570,000	123,018,000